Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. 1985

M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan

Groups of patients with newly diagnosed metastatic breast cancer who were consecutively registered into a breast cancer clinic beginning January 1956 (210 patients), January 1966 (210 patients), and January 1975 (251 patients), were analyzed to determine the impact on survival of the various treatment modalities utilized in each decade. Comparisons of survival were made among subgroups of patients with similar prognostic features. Except for patients with very poor performance status, all subgroups showed a significantly improved survival in the 1970s compared with the earlier decades. Combination chemotherapy was considered to be the major factor in the survival improvement.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013781 Texas State bounded on the north by Oklahoma, on the east by Arkansas and Louisiana, on the south by Mexico, and on the west by New Mexico.

Related Publications

M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
January 1991, European journal of cancer (Oxford, England : 1990),
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
November 1979, Cancer research,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
April 2002, Expert review of anticancer therapy,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
July 1977, British medical journal,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
February 1981, Harefuah,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
January 1988, Journal of cancer research and clinical oncology,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
January 1987, European journal of haematology. Supplementum,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
June 2011, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
January 1992, Medical oncology and tumor pharmacotherapy,
M B Ross, and A U Buzdar, and T L Smith, and N Eckles, and G N Hortobagyi, and G R Blumenschein, and E J Freireich, and E A Gehan
January 2005, The oncologist,
Copied contents to your clipboard!